Also in global health news: Sexual violence in DRC; anti-gay legislation; counterfeit drugs in Kenya

NewsGuard 100/100 Score

U.S. To Give $7M To Help Women Who Have Suffered Sexual Violence In DRC

The U.S. will finance a $7 million program to aid women in the eastern Democratic Republic of Congo who have been the targets of sexual violence, the U.S. embassy said on Tuesday, Agence France-Presse reports. The money will provide "support for clinics, hospitals and community centres for women and children," according to an embassy statement. "The project, baptised Espoir (Hope), was jointly launched by the Congolese government and the U.S. embassy and is financed by the development agency USAID" (12/22).

U.S. Lawmakers Call For Ugandan President To Oppose Anti-Gay Legislation

Five House Republicans - Reps. Frank Wolf (Va.), Chris Smith (N.J.), Joe Pitts (Penn.), Trent Franks (Ariz.) and Anh "Joseph" Cao (La.) - sent a letter to Ugandan President Yoweri Museveni on Tuesday urging him "to oppose a proposed law that would impose the death penalty for some gay Ugandans," the Associated Press reports. "The lawmakers say they are all men of faith, and that the bill is antithetical to the Christian belief of 'inherent dignity and worth' of all people," the news service writes (12/22).

HIV Patients Petition Kenyan Anti-Counterfeit Law

Inter Press Service reports on an upcoming legal challenge to Kenya's new anti-counterfeit act. Three HIV-positive people argue that the law could prevent them from obtaining generic drugs, which "could cause a health crisis as generics constitute 90 percent of medicines used in Kenya," IPS writes. "The three petitioners want the Constitutional Court to declare the law ... unconstitutional on the grounds that it will deny them access to affordable life-saving generic medicines and therefore rob them off their right to life, says Peter Munyi, an intellectual property rights lawyer working with Health Action International (HAI) Africa" (Anyangu-Amu, 12/21).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
SGLT2 inhibitors: A game-changer in preventing heart failure and sudden cardiac deaths